Latest News about LCTX
Recent news which mentions LCTX
Tickers
LCTX
From InvestorPlace
Tickers
LCTX
From InvestorPlace
Tickers
LCTX
From InvestorPlace
Tickers
LCTX
From InvestorPlace
Earnings Scheduled For March 7, 2024
March 07, 2024
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 14, 2024
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 01, 2024
From Benzinga
Lineage Cell Therapeutics, Longeveron And 2 Other Stocks Under $2 Insiders Are Buying
January 03, 2024
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 29, 2023
From Benzinga
3 Penny Stocks to Buy for the Next Bull Run
November 11, 2023
From InvestorPlace
From InvestorPlace
EXCLUSIVE: Cell Therapy Player Lineage Cell Therapeutics Starts Development Activities Under Licensing Pact With Eterna Therapeutics
September 06, 2023
From Benzinga
From Benzinga
Earnings Scheduled For August 10, 2023
August 10, 2023
From Benzinga
Lineage Cell Therapeutics' Lung Cancer Vaccine: Initial Data Reveals Modest, Durable Immune Response
July 24, 2023
Tickers
LCTX
From Benzinga
Harley-Davidson, Sportsman's Warehouse And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
April 13, 2023
From Benzinga
3 Penny Stocks to Buy During Market Downturns
April 10, 2023
From InvestorPlace
EXCLUSIVE: Lineage Cell Inks Exclusive Agreement For Novel Cell-Based Therapies With Potential In Neurology
February 22, 2023
Tickers
LCTX
From Benzinga
2022 Was A Year Of Growth, Funding, And Positive Results For BioRestorative Therapies
January 25, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
November 02, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.